(13Z)-Oxacyclohexadecen-2-one
| Strength: |
medium |
| Threshold: |
National Center for Biotechnology Information |
| Common Name: |
(13Z)-Oxacyclohexadecen-2-one |
| IUPAC Name: |
(13Z)-1-oxacyclohexadec-13-en-2-one |
| Molecular Formula: |
C15H26O2 |
| SMILES: |
C1CCCCCC(=O)OCCC=CCCCC1 |
| Inchi: |
1S/C15H26O2/c16-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-17-15/h8,10H,1-7,9,11-14H2/b10-8- |
| Inchi Key: |
AGZBJJSLDGWKSU-NTMALXAHSA-N |
| Cas No: |
111879-81-3 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
238.37 |
| Mass (g/mol) |
238.193 |
| Molar Refractivity |
72.92 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
0 |
| Rings |
1 |
| TPSA |
26.30 |
| Hetero Atoms |
2 |
| Heavy Atoms |
17 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
383.00 to 384.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.000004 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.80 |
| LogP |
4.391 |
| iLOGP |
3.19 |
| XLOGP3 |
5.35 |
| WLOGP |
4.39 |
| MLOGP |
3.44 |
| ESOL Log S |
-4.69 |
| ESOL Solubility (mg/ml) |
0.005 |
| ESOL Solubility (mol/l) |
0 |
| ESOL Class: esol_class |
Moderately soluble |
| Ali Log S |
-5.66 |
| Ali Solubility (mg/ml) |
0 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Moderately soluble |
| Silicos-IT LogSw |
-3.23 |
| Silicos-IT Solubility (mg/ml) |
0.14 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-3.96 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.762 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
1 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.587 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
